Heart Neoplasms

2

Review clinical trials related to Heart Neoplasms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study

The safety and efficacy evaluation of echocardiography-guided percutaneous radiofrequency ablation (Liwen prcocedure) for cardiac tumors: a single-arm, prospective, single-center clinical study.

Participants needed: 40
Trial details
Biological sex: AllType: InterventionalSponsor: Xijing HospitalUpdated: Feb 17, 2025Locations: 1
Eligibility criteria

Hemodynamic changes caused by cardiac tumors or patients with obvious clinical s... [+2]

Previously documented persistent ventricular tachycardia or ventricular fibrilla... [+11]

Status: Recruiting

Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics

The etiology and specific pathogenesis of many cardiovascular diseases such as coronary atherosclerosis, cardiomyopathy, atrial fibrillation, and stroke are still unclear. Improving diagnosis and treatment, clarifying the pathogenesis, and providing scientific basis for the prevention and treatment are hot research topics in the study of cardiovascular and cerebrovascular diseases. This study intends to collect clinical data and biological specimen data of patients with cardiovascular and cerebrovascular diseases who meet the inclusion and exclusion criteria, and use multi-omics technology to deeply understand the pathogenic mechanisms of cardiovascular and cerebrovascular diseases and provide new ideas for specific and individualized treatment of patients with cardiovascular and cerebrovascular diseases, to construct early predictive prognostic models and provide a basis for effective treatment of clinical practice in patients with cardiovascular and cerebrovascular diseases.

Participants needed: 25,000
Trial details
Age: 3-80Biological sex: AllType: ObservationalSponsor: First Affiliated Hospital Xi'an Jiaotong UniversityUpdated: Jul 12, 2024Locations: 1
Eligibility criteria

Patients who are regularly visited and followed up in the appropriate patient; d... [+12]

Age <3 years or >80 years old; [+3]